Showing results (1-10 of 570) with videos related to
Sort By:
Pageof 57
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1992
Reversible cardiomyopathy after high-dose interleukin-2 therapyM Goel, L Flaherty, S Lavine, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinomaB G Redman, D C Smith, L Flaherty, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1991
Sequential dacarbazine/cisplatin and interleukin-2 in metastatic melanoma: immunological effects of therapyB G Redman, L Flaherty, T H Chou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinomaB G Redman, G G Hillman, L Flaherty, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1995
Phase I trial of sequential cyclophosphamide, cyclosporin A, and interferon-alpha in patients with cancer: attempt to induce autologous graft-versus-host reaction to elicit an antitumor responseB G Redman, T H Chou, M Zalupski, et al.American Journal of Clinical Oncology|August 1, 1992
Effect of calcium replacement on the hemodynamic changes associated with high dose interleukin-2 therapyB G Redman, L Flaherty, S Martino, et al.Investigational New Drugs|August 1, 1992
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I studyE A Poplin, T Corbett, L Flaherty, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Phase I trial of recombinant macrophage colony-stimulating factor by rapid intravenous infusion in patients with cancerB G Redman, L Flaherty, T H Chou, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcomaF A Momin, M Zalupski, L K Heilbrun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
A phase I trial of recombinant interleukin-2 combined with recombinant interferon-gamma in patients with cancerB G Redman, L Flaherty, T H Chou, et al.Pageof 57